.RESEARCH STUDY EMPHASIZE.06 August 2024.
A big randomized measured test along with cisgender women highlights the problems of obedience to an everyday oral preexposure treatment regiment as well as displays that twice-yearly treatment of lenacapavir can preserve reliable HIV avoidance degrees over 6 months.